Phosphodiesterase type 5 inhibitor
Tracked across 1 events · 20 articles · First seen Aug 04, 2026 · Last active Aug 07, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
A large observational study published in the British Journal of Ophthalmology found that men taking tadalafil (Tadalafil) for lower urinary tract symptoms associated with benign prostatic hyperplasia had a 22% higher risk of developing glaucoma…
Impact: The drug class is implicated; the study suggests chronic PDE5 inhibition may affect ocular physiology, warranting further investigation.
Aug 04, 2026 · 20 articles
ERGEN INTELLIGENCE
Track Phosphodiesterase type 5 inhibitor live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard